MIT scientists engineered prime editing variants with mutations in Cas9 nickase to destabilize nicked DNA ends, promoting precise DNA repair and dramatically lowering insertion/deletion mutations (indels) that impede editing accuracy. Their Nature report outlines how altered nick positions and targeted degradation increase specificity without complicating delivery. This refinement addresses key limitations of prime editing, supporting safer and more effective applications in therapeutic gene corrections.